555win cung cấp cho bạn một cách thuận tiện, an toàn và đáng tin cậy [chốt số miền bắc]
Aug 14, 2025 · Inovio Pharmaceuticals (NASDAQ:INO - Get Free Report) posted its quarterly earnings results on Tuesday. The biopharmaceutical company reported ($0.61) earnings per …
Aug 12, 2025 · INOVIO's management will host a live conference call and webcast with slides at 4:30 p.m. ET today to discuss INOVIO's financial results and provide a general business update.
Inovio Pharmaceuticals (NASDAQ:INO) shares up after the company's net loss lowered in Q2 from the previous year period. The company reported a second quarter 2025 net loss of $0.61 …
6 days ago · Inovio Pharmaceuticals (NASDAQ:INO) Second Quarter 2025 Results Key Financial Results Net loss: US$23.5m (loss narrowed by 27% from 2Q 2024).
Mar 18, 2025 · INOVIO's management will host a live conference call and webcast with slides at 4:30 p.m. ET today to discuss INOVIO's financial results and provide a general business update.
Aug 4, 2025 · Subscribe for updates from inovio Register to receive email alerts for INOVIO press releases Email Alerts Mailing Lists *
Jul 2, 2025 · INOVIO is a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and …
5 days ago · Wall Street Zen downgraded shares of Inovio Pharmaceuticals from a 'hold' rating to a 'sell' rating in a report on Saturday.
Aug 12, 2025 · INOVIO Reports Second Quarter 2025 Financial Results and Recent Business Highlights Posted on August 12, 2025
2 days ago · 4c5053.555win5win.com - Oppenheimer has reiterated an Outperform rating and $13.00 price target on Inovio Pharmaceuticals (NASDAQ:INO) following the FDA approval of a competing …
Bài viết được đề xuất: